Antibody Production Services Market, Global Outlook and Forecast 2023-2032
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called ?antigens?). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C?sar Milstein and Georges K?hler ? scientists at the Roche-funded Basel Institute for Immunology ? who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
This report aims to provide a comprehensive presentation of the global market for Antibody Production Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Production Services. This report contains market size and forecasts of Antibody Production Services in global, including the following market information:
Global Antibody Production Services Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Antibody Production Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
IgM Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antibody Production Services include Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Antibody Production Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody Production Services Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Antibody Production Services Market Segment Percentages, by Type, 2022 (%)
IgM
IgG
IgA
Other
Global Antibody Production Services Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Antibody Production Services Market Segment Percentages, by Application, 2022 (%)
Therapeutic
Research
Diagnostic
Global Antibody Production Services Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Antibody Production Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antibody Production Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antibody Production Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antibody Production Services, market overview.
Chapter 2: Global Antibody Production Services market size in revenue.
Chapter 3: Detailed analysis of Antibody Production Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antibody Production Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
